Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $81.0700 (0.95%) ($79.5000 - $81.2400) on Thu. Jun. 13, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.07% (three month average) | RSI | 37 | Latest Price | $81.0700(0.95%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | UTHR declines -3.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) XLV(43%) IBB(41%) VYM(40%) XBI(40%) VFMO(39%) | Factors Impacting UTHR price | UTHR will decline at least -1.035% in a week (0% probabilities). VXX(-20%) TLT(-13%) IFRA(-3%) UUP(-0%) TIP(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.035% (StdDev 2.07%) | Hourly BBV | 0 () | Intraday Trend | 0.5% | | | |
|
1 - 5 Day Possible Target | $75.77(-6.54%) | Resistance Level | $84.89 | 5 Day Moving Average | $81.39(-0.39%) | 10 Day Moving Average | $82.38(-1.59%) | 20 Day Moving Average | $84.89(-4.5%) | To recent high | -34.1% | To recent low | 0.9% | Market Cap | $3.596b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |